World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 72 19783 18555 9847 9075 241 23725

James W. Mier publications per year

The chart shows the history of publications by James W. Mier between 1980 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. James W. Mier published across 44 years, from 1980 to 2023, averaging 6.6 papers a year. Output peaked at 46 publications in 2023. 46 of the 289 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1980 to 2023. Vertical axis: number of publications, 0 to 46. Peak 46 publications in 2023. 1980: 4 publications 1981: 1 publication 1982: 6 publications 1983: 2 publications 1984: 0 publications 1985: 2 publications 1986: 4 publications 1987: 4 publications 1988: 10 publications 1989: 2 publications 1990: 8 publications 1991: 6 publications 1992: 7 publications 1993: 11 publications 1994: 6 publications 1995: 3 publications 1996: 3 publications 1997: 8 publications 1998: 4 publications 1999: 1 publication 2000: 6 publications 2001: 10 publications 2002: 2 publications 2003: 6 publications 2004: 8 publications 2005: 4 publications 2006: 7 publications 2007: 2 publications 2008: 7 publications 2009: 10 publications 2010: 6 publications 2011: 7 publications 2012: 8 publications 2013: 10 publications 2014: 7 publications 2015: 11 publications 2016: 13 publications 2017: 8 publications 2018: 4 publications 2019: 9 publications 2020: 6 publications 2021: 0 publications 2022: 0 publications 2023: 46 publications
1980 2023

289 publications in total across all disciplines

View publications per year as a table
James W. Mier: publications per year, 1980 to 2023
Year Publications
1980 4
1981 1
1982 6
1983 2
1984 0
1985 2
1986 4
1987 4
1988 10
1989 2
1990 8
1991 6
1992 7
1993 11
1994 6
1995 3
1996 3
1997 8
1998 4
1999 1
2000 6
2001 10
2002 2
2003 6
2004 8
2005 4
2006 7
2007 2
2008 7
2009 10
2010 6
2011 7
2012 8
2013 10
2014 7
2015 11
2016 13
2017 8
2018 4
2019 9
2020 6
2021 0
2022 0
2023 46
Total 289
Download as CSV

James W. Mier publications per year - data summary

  • James W. Mier, a Medicine scholar from Beth Israel Deaconess Medical Center, has 289 publications recorded across 44 years, from 1980 to 2023.
  • The oldest publication on record dates to 1980 and the most recent to 2023.
  • The most productive year is 2023, with 46 publications.
  • The least productive years with any output are 1981 and 1999, with 1 publication each.
  • 3 of the 44 years in the span carry no publications at all (1984, 2021 and 2022).
  • The rate of publication averages 6.6 papers per year over the whole span, or 7.0 per year counting only the 41 years with at least one publication.
  • The last 5 years on the chart (2019-2023) hold 61 publications, 21% of the career total.
  • Split into equal eras - 1980-1994: 73 publications (4.9 per year); 1995-2009: 81 publications (5.4 per year); 2010-2023: 135 publications (9.6 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

James W. Mier publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James W. Mier sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 241–260 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 241 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545 241
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

James W. Mier publication distribution in Medicine in 2026 - data summary

  • The chart plots the publication count of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 86 ranges running from 101–120 to 1,796+ publications.
  • James W. Mier, a Medicine scholar from Beth Israel Deaconess Medical Center, records 241 publications - the 7th percentile of the discipline.
  • 7% of ranked Medicine scientists score the same or lower than James W. Mier, and about 93% score higher.
  • The median of the discipline falls in the 441–460 publications range, and James W. Mier ranks below the median.
  • The most crowded range is 341–360 publications, holding 922 scientists (5% of the field).
  • 64% of the field sits in the lowest quarter of the value range (up to 521–540 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 1,796 publications or more, 100 scientists in all (<1% of the field).

James W. Mier D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James W. Mier sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 72–73 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391 72
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

James W. Mier D-index placement in Medicine in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 75 ranges running from 70–71 to 217+ D-Index.
  • James W. Mier, a Medicine scholar from Beth Israel Deaconess Medical Center, records 72 D-Index - the 2nd percentile of the discipline.
  • 2% of ranked Medicine scientists score the same or lower than James W. Mier, and about 98% score higher.
  • The median of the discipline falls in the 94–95 D-Index range, and James W. Mier ranks below the median.
  • The most crowded range is 82–83 D-Index, holding 1,027 scientists (5% of the field).
  • 70% of the field sits in the lowest quarter of the value range (up to 106–107 D-Index), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 217 D-Index or more, 98 scientists in all (<1% of the field).

Overview

James W. Mier is affiliated with Beth Israel Deaconess Medical Center in the United States. Their research primarily focuses on medicine, with a significant emphasis on oncology, molecular biology, obstetrics and gynecology, cancer research, and reproductive medicine.

Their scientific work covers various topics related to cancer treatment and molecular biology, including:

  • Endometrial and cervical cancer treatments
  • Cancer immunotherapy and biomarkers
  • Cancer-related molecular pathways
  • Ovarian cancer diagnosis and treatment
  • Angiogenesis and VEGF in cancer
  • Prostate cancer treatment and research
  • CAR-T cell therapy research

James W. Mier has contributed to several publications, primarily in the following venues:

  • Journal of Clinical Oncology
  • Molecular Cancer

Selected recent papers by Mier include:

  • Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer, 2020, Journal of Clinical Oncology
  • Lenvatinib (LEN) plus pembrolizumab (PEMBRO) for early-line treatment of advanced/recurrent endometrial cancer (EC), 2020, Journal of Clinical Oncology
  • Association of an RNA signature (RS) with emergence of ICOS hi CD4 T cells and efficacy outcomes for the ICOS agonist vopratelimab (vopra) and nivolumab (nivo) in patients (pts) on the ICONIC trial, 2020, Journal of Clinical Oncology
  • Retraction Note to: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells, 2021, Molecular Cancer
  • Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma, 2021, Molecular Cancer

Their frequent collaborators include:

  • Vicky Makker
  • Matthew H. Taylor
  • Carol Aghajanian
  • Ana Oaknin
  • Allen Lee Cohn

Best Publications

  • Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55

    Herbert Tilg;Elizabeth Trehu;Michael B. Atkins;Charles A. Dinarello

  • Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion

    Arnold H. Zea;Paulo C. Rodriguez;Michael B. Atkins;Claudia Hernandez

  • Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma

    David F. McDermott;Meredith M. Regan;Joseph I. Clark;Lawrence E. Flaherty

  • IL-6 and APPs: anti-inflammatory and immunosuppressive mediators.

    Herbert Tilg;Charles A. Dinarello;James W. Mier

  • Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

    Arthur Kaser;Gerald Brandacher;Wolfgang Steurer;Susanne Kaser;Susanne Kaser

  • Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

    Michael B. Atkins;Michael J. Robertson;Michael Gordon;Michael T. Lotze

  • Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

    George D. Kamphaus;Pablo C. Colorado;David J. Panka;Helmut Hopfer

  • Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma

    Jeffrey J. Wallin;Johanna C. Bendell;Roel Funke;Mario Sznol

  • Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer

    Michael Atkins;Meredith Regan;David McDermott;James Mier

  • Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.

    David Avigan;Baldev Vasir;Jianlin Gong;Virginia Borges

  • Multiple biological activities of human recombinant interleukin 1.

    C A Dinarello;J G Cannon;J W Mier;H A Bernheim

  • Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer Cells: A Phase II Clinical Trial

    Fisher Ri;Coltman Ca;Doroshow Jh;Rayner Aa

  • Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor

    Joseph E. Gootenberg;Francis W. Ruscetti;James W. Mier;Adi Gazdar

  • Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.

    Vicky Makker;Drew Rasco;Nicholas J Vogelzang;Marcia S Brose

  • Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells.

    Michael B. Atkins;James W. Mier;David R. Parkinson;Jody A. Gould

  • Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

    Vicky Makker;Matthew H. Taylor;Carol Aghajanian;Ana Oaknin

  • Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.

    Jared A. Gollob;James W. Mier;Korina Veenstra;David F. McDermott

  • Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells.

    David J. Panka;Toshiaki Mano;Toshimitsu Suhara;Kenneth Walsh

  • T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor

    Bernard J. Poiesz;Francis W. Ruscetti;James W. Mier;Andrea M. Woods

  • Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media

    James W. Mier;Robert C. Gallo

Frequent Co-Authors

Michael B. Atkins
Michael B. Atkins Georgetown University
Sabina Signoretti
Sabina Signoretti Brigham and Women's Hospital
David F. McDermott
David F. McDermott Beth Israel Deaconess Medical Center
Charles A. Dinarello
Charles A. Dinarello University of Colorado Anschutz Medical Campus
Jeffrey A. Sosman
Jeffrey A. Sosman Northwestern University
Kim Margolin
Kim Margolin City Of Hope National Medical Center
Ryan J. Sullivan
Ryan J. Sullivan Harvard University
Richard I. Fisher
Richard I. Fisher Fox Chase Cancer Center
David C. Alsop
David C. Alsop Beth Israel Deaconess Medical Center
Geoffrey I. Shapiro
Geoffrey I. Shapiro Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical studies in the USA opens up a range of allied health careers beyond the traditional MD route. Many students are now choosing flexible online pathways to accelerate or specialize their medical education. For example, easiest online dnp programs appeal to nurses who want to advance into leadership or specialist roles without leaving their current jobs.

If you’re looking for a quicker entry into healthcare, exploring fast track medical programs such as online LPN courses can help you join the workforce sooner. For those interested in mental health, the fastest psych np program options allow registered nurses to specialize rapidly and start making a difference in behavioral health care.

Healthcare administration is another growing field. The best online mha programs offer affordable, flexible education for those who want to lead health organizations or manage hospital systems. Choosing the right online degree can help you reach your career goals in medicine and healthcare more efficiently.

Best Scientists Citing James W. Mier

Trending Scientists

Recently Published Articles